Here we present the first demonstration that 2-deoxy-2[18F]fluoro-D-glucose (18FDG) and micro Positron Emission Tomography (microPET) can be used successfully to monitor regional changes in brain metabolism during acute seizure induction in C57Bl/6 mice. These longitudinal studies show a significant increase in 18FDG uptake in the hippocampus (33.2%) which correlates directly with seizure severity (R2=0.86). 18FDG microPET can potentially be used to monitor the development of TLE in mouse models from the acute phase of status epilepticus to the chronic phase of spontaneous recurrent seizures. These studies provide a foundation upon which we can begin to identify genetic contributions to the metabolic signature of TLE in mice, since many transgenics are in the C57Bl/6 background strain.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/syn.20216 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
High-iron diet damages brown adipose tissue mitochondria and exacerbates metabolic hazards of a high-fat diet.
Biochem Biophys Res Commun
December 2024
Air Force Medical University. Xi'an, Shaanxi Province, 710032, China. Electronic address:
Article Synopsis
- - The study investigated how a high-fat, high-iron animal diet affects metabolism in mice, using various imaging and analysis techniques to evaluate changes in brown adipose tissue (BAT) and overall metabolic functions.
- - Results showed that this diet increased appetite, impaired glucose tolerance, and reduced insulin sensitivity, while also raising oxidative stress in mitochondria and lowering their function.
- - Findings suggest that simply reducing carbohydrates and increasing animal products may harm metabolic health long-term, highlighting the importance of dietary diversity and monitoring caloric intake for better outcomes.
Targeted Positron Emission Tomography-Tracked Biomimetic Codelivery Synergistically Amplifies Ferroptosis and Pyroptosis for Inducing Lung Cancer Regression and Anti-PD-L1 Immunotherapy Efficacy.
ACS Nano
November 2024
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Peking University, Beijing 100142, China.
Article Synopsis
- * These nanovesicles, loaded with Polyphyllin VI (PPVI) and CDDP, showed high radiochemical purity and stability, and demonstrated improved tumor targeting through micro-PET imaging.
- * PPVI not only boosted CDDP sensitivity by promoting cell death pathways but also increased immune cell infiltration in tumors, with combined therapy showing a significant regression of NSCLC, offering a promising approach for integrated cancer treatment and monitoring.
Preclinical Evaluation of a Radiolabeled Pan-RAF Inhibitor for RAF-Specific PET/CT Imaging.
Mol Pharm
October 2024
College of Physics, Jilin University, Changchun 130012, People's Republic of China.
Abnormalities in the RAS-RAF signaling pathway occur in many solid tumors, leading to aberrant tumor proliferation, invasion, and metastasis. Due to the elusive pharmacology of RAS, RAF inhibitors have become the main targeted therapeutic drugs. Naporafenib (LXH-254) is a high-affinity pan-RAF inhibitor with FDA Fast Track Qualification.
View Article and Find Full Text PDFEvaluation of damage discrimination in dopaminergic neurons using dopamine transporter PET tracer [F]FECNT-d.
EJNMMI Res
August 2024
NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, No. 20 Qianrong Road, Binhu District, Wuxi, 214063, China.
Background: Parkinson's disease (PD) is a prevalent neurodegenerative disorder worldwide, diagnosed based on classic symptoms like motor dysfunction and cognitive impairments. With the development of various radioactive ligands, positron emission tomography (PET) imaging combined with specific radiolabelling probes has proven to be effective in aiding clinical PD diagnosis. Among these probes, 2β-Carbomethoxy-3β-(4-chlorophenyl)-8-(2-[F]-fluoroethyl) nortropane ([F]FECNT) has been utilized as a PET tracer to image dopamine transporter (DAT) integrity in striatal presynaptic dopaminergic terminals.
View Article and Find Full Text PDFOn the shoulder of ADC: The development of I-IMMU-132, an iodine-124-labelled Trop-2-targeting molecular probe for micro-PET imaging.
Biomed Pharmacother
September 2024
Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing 100142, China. Electronic address:
Background: Trop-2 is closely related to the development and progression of a variety of tumours and poor prognosis. This study aimed to construct an iodine-124 (I)-labelled antibody-drug conjugate (ADC) positron emission tomography (PET) probe which could noninvasively image Trop-2 in vivo, providing an important method for the diagnosis of tumours with high Trop-2 expression in clinical practice and monitoring their treatment.
Methods: In this study, a novel Trop-2-targeting molecular probe, I-IMMU-132, was constructed to better reveal the expression of Trop-2.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!